Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-21

Clinical Trial Update: Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the additional antiemetic effect of Ramosetron prophylaxis after total knee arthroplasty. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramosetron (ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED | Results posted: 2010-05-21